[O-]C(=O)C1=CC=CC=C1C1C2=CC(Br)=C([O-])C(Br)=C2OC2C=1C=C(Br)C(=O)C=2Br
Smiles: CN(C)C1=CC(=CC=C1)C1=C2C(=CC(=O)N1C)NN(C1=CC=CC=C1Cl)C2=O
InChiKey: YDIKCZBMBPOGFT-PWUSVEHZSA-N
IL-4 and total protein concentrations
Cyamemazine antagonizes 5-HT3 and 5-HT2C receptors and that this effect is partially involved in its therapeutic activity in anxiety disorders
NNGH - CAS# 161314-17-6 798CG-100602 [O-]C(=O)C1=CC=CC=C1C1C2=CC(Br)=C([O-])C(Br)=C2OC2C=1C=C(Br)C(=O)C=2BrKi: 9, 2. 6, 4. 3, 3. 1, and 17 nM for MMP 8, 9, 12, 13, and 20, respectively. NNGH is an inhibitor of MMPs. Matrix metalloproteinases (MMPs), a large class of strictly related zincdependent enzymes, belong to the family of proteolytic enzymes. MMPs are involved in various aspects of physiological cellular processes and pathologies, such as pulmonary emphysema, reumathoid arthritis, tumor growth and metastasis. In vitro: Previous study found that NNGH